American College of Surgeons Oncology Group

美国外科学院肿瘤学组

• 批准号: 7496267
• 负责人: DAVID M. OTA
• 金额: $ 30万
• 依托单位: DUKE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 1998
• 资助国家: 美国
• 起止时间: 1998-05-15 至 2007-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7496267
• 关键词: Academic Medical Centers; American College of Surgeons; American College of Surgeons Oncology Group; Americas; Area; Biological Markers; Cancer Trials Support Unit; Clinical Research; Clinical Trials; Commit; Communities; Community Practice; Country; Devices; Diagnosis; Diagnostic; Imaging Techniques; Incidence; Malignant - descriptor; Malignant Neoplasms; Medical Oncology; Minority; Neoadjuvant Therapy; Operative Surgical Procedures; Patient Participation; Patients; Physicians; Positioning Attribute; Private Practice; Research; Research Design; Resources; Role; Solid Neoplasm; Surgeon; Surgical Oncologist; Surgical Specialties; Therapeutic; Underserved Population; United States; Woman; college; innovation; medical specialties; mortality; neoplasm resource; new technology; programs

The American College of Surgeons Oncology Group (ACOSOG) was established to define the role of surgical therapies in the management of patients with malignant solid tumors. The ACOSOG incorporates general and specialty surgical oncologists as well as non-surgical oncologists, in academic medical centers and community practices throughout the United States of America and foreign countries. This surgical group is important to the oncologic community because of the primary role of surgery in the treatment of patients with cancer. ACOSOG trials will evaluate several areas of surgical and medical oncology. The most important are: a) new and existing operative procedures, b) new technologies and devices, c) clinical studies that are designed for neoadjuvant therapy, d) diagnostic molecular markers and therapeutic biologic agents, e) radiographic imaging procedures and f) interventional therapies in patients diagnosed with certain solid tumors that are less accessible to other cooperative groups. The ACOSOG will participate in trials offered through the Cancer Trials Support Unit (CTSU) when the Group's resources and access to surgical patients can substantially enhance accrual to those trials. ACOSOG benefits from its strong relationship with the American College of Surgeons (ACOS), the largest organization of surgeons in the world, which possesses an extensive geographic membership including general and specialty surgeons in both academic and private practice. Also, the interrelationship of the ACOSOG with the ACOS provides a unique opportunity to utilize the resources of the Cancer Department of the College to develop research and educational programs to support ACOSOG clinical trials. This diverse membership of the ACOS also positions ACOSOG to offer clinical trials to women, minorities and underserved populations. The ACOSOG is committed to lowering cancer incidence and mortality through innovative clinical trials allowing broad physician and patient participation.

美国外科医师学会肿瘤学小组（ACOSOG）的成立是为了确定外科治疗的作用 在恶性实体瘤患者的管理中。ACOSOG包括普通和专业外科手术 肿瘤学家以及非手术肿瘤学家，在学术医疗中心和社区实践，在整个 美国和其他国家。这个外科小组对肿瘤学界很重要，因为 手术在治疗癌症患者中的主要作用。 ACOSOG试验将评估外科和内科肿瘤学的几个领域。最重要的是：a）新的和 现有手术程序，B）新技术和器械，c）针对新辅助治疗设计的临床研究 治疗，d）诊断性分子标记物和治疗性生物制剂，e）放射成像程序和f） 在诊断患有某些实体瘤的患者中进行介入治疗，这些实体瘤不太容易获得其他合作治疗。 组ACOSOG将参加通过癌症试验支持单位（CTSU）提供的试验， 集团的资源和获得手术患者可以大大提高这些试验的收益。 ACOSOG受益于其与美国外科医生学会（ACOS）的牢固关系，ACOS是美国最大的外科医生学会。 世界外科医生组织，拥有广泛的地理成员，包括一般和 专业外科医生在学术和私人执业。此外，特别行动组与行动指挥官之间的相互关系 提供了一个独特的机会，利用学院的癌症部门的资源，以发展研究和 支持ACOSOG临床试验的教育计划。ACOS成员的多样性也使 ACOSOG将为妇女、少数民族和服务不足的人群提供临床试验。 ACOSOG致力于通过创新的临床试验降低癌症发病率和死亡率， 广泛的医生和患者参与。